Ledger.Open graph →
SEC Form D · filed August 26, 2020

Inhalon Biopharma, Inc

Offering
$3.6M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CARRBORO, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Winnie B. Wan · Carrboro, NCDirectorSamuel B. Lai · Carrboro, NCExec · DirectorJohn B. Whelan · Carrboro, NCExec · DirectorDaniel Dahan · Thornhill, Ontario, CanadaExec · DirectorLuke Buchanan · Columbus, OHExec · DirectorJaimin Gandhi · Columbus, OHDirectorAnthony Tomasello · Chicago, ILExec · DirectorJames Q. Mi · Grand Cayman, Cayman IslandsDirectorJohn E. Parker · Newtown, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗